Company intelligence / Profile preview

Doc Lab

United States

Ownership: Private
Development stage: Other

Overview

Doc Lab Inc offers decentralized, high complexity reference laboratories for private practices using advanced PCR-based diagnostics, including rapid in-office testing with turnaround reduction of over 75% versus traditional labs. No direct clinical trials (as service/equipment provider), but reports very high efficiency and improved diagnostic accuracy for infectious diseases.

Therapeutic areas: Infectious Diseases
Modalities: PCR molecular testing (including for infectious diseases)
Industry: Molecular Diagnostics

Partnerships

Private healthcare practicesNo major pharma/biotech partnerships disclosed

Beyond the preview

Go deeper on Doc Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Doc Lab.

Explore the full profile